Skip to content
DraconiticResearch
Search Sources API
181,716 studies31 sourcesUpdated 32 min ago
Peer-reviewedCC BY 4.0Nutrients

Regioselective Derivatization of Flavonoids: Bridging Synthetic Chemistry and Pharmacological Efficacy

  1. 1Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ 07102, USA
  2. 2Department of Biology and Biochemistry, Saint Elizabeth University, Morristown, NJ 07960, USA
  3. 3The FoodNiche Institute, Mount Olive, NJ 07828, USA

Abstract

Natural flavonoids display diverse therapeutic capabilities, including potent antioxidant, anti-inflammatory, neuroprotective, and anticancer properties. However, poor aqueous solubility, rapid metabolic clearance, and low oral bioavailability severely constrain their translational success. This review critically evaluates recent synthetic strategies designed to overcome these pharmacokinetic bottlenecks through targeted chemical derivatization of flavonoid scaffolds. We focus on regioselective modifications—specifically acetamidation, phosphorylation, amidation, sulfonation/sulfamylation and systematically evaluate their impacts on structure–activity relationships (SAR), physicochemical stability, and biological performance. Acetamide functionalization strengthens target affinity within kinase ATP-binding pockets and prolongs metabolic half-life by shielding vulnerable phenolic sites. Phosphorylated derivatives serve as highly soluble (>100-fold increase in water solubility), bioreversible prodrugs that undergo targeted enzymatic cleavage in tissues, while sulfonated and sulfamate analogs preserve core radical-scavenging capabilities while resisting autoxidation in physiological media. Furthermore, amino acid modification of flavonoids via semi-synthetic conjugates, such as quercetin para-aminobenzoic acid (Q-PABA), demonstrates synergistic dual-action photoprotection and enhanced pro-apoptotic anticancer activity. By integrating chemical, structural, and pharmacological perspectives, this review establishes a mechanistic framework for rational flavonoid design, paving the way for next-generation natural product-derived therapeutics with optimized bioavailability and clinical efficacy.

Related

  1. Integrated pharmacological and structural profiling reveals CB1 residue interaction patterns associated with synthetic cannabinoid receptor agonist efficacy
    H. Kwon, C. k. Lee, J.-H. Kwak +1
    bioRxivPreprintCC BY-NC-NDFull textPharmacology & toxicologybioRxiv
  2. Icariin, a Multi-Target Natural Neuroprotectant, and a Comprehensive Review on Its Synthetic Methods, Pharmacological Evaluation and Pharmacokinetic Characteristics
    Kecan Zhang, Jiaxin Li, Weikang Ban +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  3. Consecutive hydrodefluorination for the regioselective synthesis of partially fluorinated arenes
    Yanxian Tan, Howard Toh, Chieh-Yu Chang +1
    ChemRxivPreprintCC BY-NC-NDFull textPharmacology & toxicologyChemRxiv
  4. Ultrasound-assisted deep eutectic solvent extraction of total flavonoids from Houttuynia cordata Thunb. and their in vitro activity
    Yu Zhang, Min Liu, Lifen Meng
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  5. Integrated proteomic and metabolomic analysis reveals the mechanism of astragalus complanatus flavonoids against liver fibrosis in rats
    Ruina Zhou, Yang Wang, Xinbo Shi +5
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
BibTeX
@article{gaddi2026regioselective,
  title = {{Regioselective Derivatization of Flavonoids: Bridging Synthetic Chemistry and Pharmacological Efficacy}},
  author = {Eshun Gaddi and Anna Popola and Julia B. Olayanju and Sadik A. Omowunmi},
  journal = {Nutrients},
  year = {2026},
  month = oct,
  doi = {10.3390/nu18213558},
  url = {https://www.mdpi.com/2072-6643/18/21/3558},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Regioselective Derivatization of Flavonoids: Bridging Synthetic Chemistry and Pharmacological Efficacy
AU  - Eshun Gaddi
AU  - Anna Popola
AU  - Julia B. Olayanju
AU  - Sadik A. Omowunmi
PY  - 2026
DA  - 2026/10/28
JO  - Nutrients
DO  - 10.3390/nu18213558
UR  - https://www.mdpi.com/2072-6643/18/21/3558
AB  - Natural flavonoids display diverse therapeutic capabilities, including potent antioxidant, anti-inflammatory, neuroprotective, and anticancer properties. However, poor aqueous solubility, rapid metabolic clearance, and low oral bioavailability severely constrain their translational success. This review critically evaluates recent synthetic strategies designed to overcome these pharmacokinetic bottlenecks through targeted chemical derivatization of flavonoid scaffolds. We focus on regioselective modifications—specifically acetamidation, phosphorylation, amidation, sulfonation/sulfamylation and systematically evaluate their impacts on structure–activity relationships (SAR), physicochemical stability, and biological performance. Acetamide functionalization strengthens target affinity within kinase ATP-binding pockets and prolongs metabolic half-life by shielding vulnerable phenolic sites. Phosphorylated derivatives serve as highly soluble (>100-fold increase in water solubility), bioreversible prodrugs that undergo targeted enzymatic cleavage in tissues, while sulfonated and sulfamate analogs preserve core radical-scavenging capabilities while resisting autoxidation in physiological media. Furthermore, amino acid modification of flavonoids via semi-synthetic conjugates, such as quercetin para-aminobenzoic acid (Q-PABA), demonstrates synergistic dual-action photoprotection and enhanced pro-apoptotic anticancer activity. By integrating chemical, structural, and pharmacological perspectives, this review establishes a mechanistic framework for rational flavonoid design, paving the way for next-generation natural product-derived therapeutics with optimized bioavailability and clinical efficacy.
SN  - 2072-6643
ER  -